featured
FDA OKs Marketing of New Test to Help Diagnose Alzheimer Disease
Lumipulse G β-Amyloid Ratio (1-42/1-40) test is first in vitro diagnostic test for early detection of amyloid plaques associated with Alzheimer disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.